{"id":3282,"date":"2023-02-16T18:49:32","date_gmt":"2023-02-16T17:49:32","guid":{"rendered":"https:\/\/iuc-aphp-sorbonneuniversite.com\/structure-recherche\/iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique\/"},"modified":"2023-03-03T15:00:52","modified_gmt":"2023-03-03T14:00:52","slug":"iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique","status":"publish","type":"structure-recherche","link":"https:\/\/iuc-aphp-sorbonneuniversite.com\/en\/structure-recherche\/iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique\/","title":{"rendered":"IPLESP &#8211; Pierre Louis Institute of Epidemiology and Public Health"},"content":{"rendered":"<div class=\"entry-content\">\n<h2>Summary of the activity<\/h2>\n<p>The Pierre Louis Institute of Epidemiology and Public Health brings together all of the Sorbonne University&#8217;s epidemiology and public health research forces. The Institute covers the main fields of epidemiology, whether clinical, population or social, as well as pharmacoepidemiology, biostatistics, statistical and mathematical modelling, clinical research, the relationship between the environment and health, the social determinants of health and health care organizations. In terms of applications, we mainly deal with communicable diseases (influenza, HIV infection, viral hepatitis, etc.), nosocomial and emerging infections, chronic diseases (chronic inflammatory diseases, respiratory, allergic and cardiovascular diseases, psychiatric diseases), and care in intensive care.<\/p>\n<p>&nbsp;<\/p>\n<h2>Site\/location and physical address<\/h2>\n<\/div>\n<p>Saint-Antoine Hospital<br \/>\nFaculty of Medicine<br \/>\nSorbonne University<br \/>\n27 rue de Chaligny &#8211; 75012 PARIS<\/p>\n<p>&nbsp;<\/p>\n<div class=\"entry-content\">\n<h2>Website<\/h2>\n<p><a href=\"https:\/\/cimiparis.fr\/\">cimiparis.fr<\/a><\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<div class=\"entry-content\">\n<h2>Contact<\/h2>\n<p><strong>Mail:<\/strong><a href=\"mailto:u1136-contact@iplesp.upmc.fr\"> u1136-contact@iplesp.upmc.fr<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Phone:<\/strong><br \/>\n+33 (0) 1 44 73 86 43<br \/>\n+33 (0)1 44 73 84 46<br \/>\n+33 (0)1 42 16 42 72<\/p>\n<p>&nbsp;<\/p>\n<h2>Guardianship<\/h2>\n<p><strong>INSERM and Sorbonne University<\/strong><\/p>\n<p>&nbsp;<\/p>\n<h2>Director \/ Head of structure<\/h2>\n<p><strong>CARRAT Fabrice<br \/>\nCOSTAGLIOLA Dominique<\/strong><\/p>\n<p>&nbsp;<\/p>\n<h2>Research units<\/h2>\n<hr \/>\n<\/div>\n<h3>CLEPIVIR team: Clinical epidemiology of chronic viral diseases<\/h3>\n<div class=\"entry-content\">\n<p>The researchers of this team coordinate large thematic cohorts of people living with HIV, chronic viral hepatitis C, B and\/or Delta, or HIV-hepatitis co-infection. They develop and use specific statistical methods to estimate the effect of treatments from observational data. The team&#8217;s scientific objectives are to quantify the benefits, risks and cost-effectiveness of antiviral management strategies for these chronic viral infections, to evaluate the co-morbidities induced by these infections or by the treatments &#8211; in particular cancers, cardiovascular or metabolic complications &#8211; and the strategies to prevent them. The team&#8217;s scientific objectives are to quantify the benefits, risks and cost-effectiveness of antiviral management strategies for these chronic viral infections, to evaluate the co-morbidities induced by these infections or by the treatments &#8211; in particular cancers, cardiovascular or metabolic complications &#8211; and the strategies to prevent them.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Website<\/strong><\/p>\n<p><a href=\"https:\/\/www.iplesp.upmc.fr\/fr\/team\/CLEPIVIR\">https:\/\/www.iplesp.upmc.fr\/fr\/team\/CLEPIVIR<\/a><\/p>\n<p><strong>Manager \/ Team Leader<\/strong><\/p>\n<p>Fabrice Carra<\/p>\n<\/div>\n<hr \/>\n<div class=\"entry-content\">\n<h3>Team THERAVIR: Therapeutic strategies against HIV infection and associated viral diseases<\/h3>\n<div class=\"entry-content\">\n<p>The researchers of this team coordinate large thematic cohorts of people living with HIV, chronic viral hepatitis C, B and\/or Delta, or HIV-hepatitis co-infection. They develop and use specific statistical methods to estimate the effect of treatments from observational data. The team&#8217;s scientific objectives are to quantify the benefits, risks and cost-effectiveness of antiviral management strategies for these chronic viral infections, to evaluate the co-morbidities induced by these infections or by the treatments &#8211; in particular cancers, cardiovascular or metabolic complications &#8211; and the strategies to prevent them. The team&#8217;s scientific objectives are to quantify the benefits, risks and cost-effectiveness of antiviral management strategies for these chronic viral infections, to evaluate the co-morbidities induced by these infections or by the treatments &#8211; in particular cancers, cardiovascular or metabolic complications &#8211; and the strategies to prevent them.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Website<\/strong><\/p>\n<p><a href=\"https:\/\/www.iplesp.upmc.fr\/fr\/team\/THERAVIR\">https:\/\/www.iplesp.upmc.fr\/fr\/team\/THERAVIR<\/a><\/p>\n<p><strong>Manager \/ Team Leader<\/strong><\/p>\n<p>Anne-Genevi\u00e8ve Marcellin<br \/>\nChristine Katlama<\/p>\n<hr \/>\n<\/div>\n<div class=\"entry-content\">\n<h3>ERES team: Research team in social epidemiology<\/h3>\n<div class=\"entry-content\">\n<p>The general objectives of the ERES are to improve knowledge about the social determinants of health and to evaluate the impact of interventions and policies aimed at reducing social inequalities in health and access to care. The results produced by the ERES contribute to helping public health professionals and decision-makers adapt their practices in a context where, as in most industrialized countries, social inequalities in health have increased in recent years, despite a continuous increase in longevity. The specificity of our team is to include researchers specialized in the study of different aspects of health (cancer, mental health, addictions, screening and preventive practices) but also investigators, who have a broad perspective and focus on determinants of social inequalities in multiple domains of health (living areas, primary care) and\/or particular populations (adolescents, pregnant women), some of which are hard to reach or marginalized (homeless people, immigrants). ERES has long-standing collaborations with clinicians (primary care, HIV, psychiatry), social scientists (sociology, geography, political science), and biostatisticians, both within and outside of IPLESP, creating an interdisciplinary environment.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Website<\/strong><\/p>\n<p><a href=\"https:\/\/www.iplesp.upmc.fr\/fr\/team\/ERES\">https:\/\/www.iplesp.upmc.fr\/fr\/team\/ERES<\/a><\/p>\n<p><strong>Manager \/ Team Leader<\/strong><\/p>\n<p>Maria Melchior<\/p>\n<\/div>\n<\/div>\n<hr \/>\n<div class=\"entry-content\">\n<div class=\"entry-content\">\n<div class=\"entry-content\">\n<h3>Team SUMO &#8211; Surveillance and Modeling of Communicable Diseases<\/h3>\n<div class=\"entry-content\">\n<p>The &#8220;Surveillance and Modeling of Communicable Diseases&#8221; team brings together researchers specialized in the development of epidemiological information systems for the surveillance of communicable diseases and the analysis of their dissemination, particularly through modeling approaches. Communicable diseases remain a major public health problem. The different types of mobility, regional and global, allow an ever more rapid spread of infectious pathogens, creating the conditions for the emergence of new diseases. These phenomena are also supported by individual behavioral choices, from vaccine hesitancy reducing population protection to inappropriate antibiotic use increasing bacterial resistance.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Website<\/strong><\/p>\n<p><a href=\"https:\/\/www.iplesp.upmc.fr\/fr\/team\/SUMO\">https:\/\/www.iplesp.upmc.fr\/fr\/team\/SUMO<\/a><\/p>\n<p><strong>Manager \/ Team Leader<\/strong><\/p>\n<p>Pierre-Yves BO\u00cbLLE<\/p>\n<hr \/>\n<\/div>\n<\/div>\n<div class=\"entry-content\">\n<h3>NEMESIS Team: Environment, Mobility and Health<\/h3>\n<div class=\"entry-content\">\n<p>The two research objectives of the Nemesis team are to investigate how environments and neighborhoods affect health and to explore the impact of mobility and transportation on health. As for the first objective, our contribution is to investigate the contextual and environmental determinants of health behaviors and health using detailed spatio-temporal data. As for the second objective, we seek to develop a comprehensive model of the relationship between transportation and health integrating the physical activity benefits of active transportation but also the exposures to air pollutants and noise as well as the stress experienced in the different modes of transportation.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Website<\/strong><\/p>\n<p><a href=\"https:\/\/www.iplesp.upmc.fr\/fr\/team\/NEMESIS\">https:\/\/www.iplesp.upmc.fr\/fr\/team\/NEMESIS<\/a><\/p>\n<p><strong>Manager \/ Team Leader<\/strong><\/p>\n<p>Basile CHAIX<\/p>\n<hr \/>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"entry-content\">\n<div class=\"entry-content\">\n<div class=\"entry-content\">\n<h3>PEPITES team: Pharmacoepidemiology and evaluation of care<\/h3>\n<div class=\"entry-content\">\n<p>The scientific themes of the PEPITES team are pharmacoepidemiology (i.e. the evaluation of health products &#8211; drugs and medical devices &#8211; in real-life situations) and health care evaluation. More precisely, our research concerns populations at high risk due to specific characteristics (e.g. elderly people or patients in intensive care), the evaluation of the benefit\/risk of biomedicines whatever the indication, the evaluation of the organization of care with a particular interest in the trajectories of patients and the key moments of transition (e.g. admission, the stay in the hospital proper or the discharge from the hospital and the transition with the city or the follow-up care) and their consequences on the benefit\/risk of the health products.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Website<\/strong><\/p>\n<p><a href=\"https:\/\/www.iplesp.upmc.fr\/fr\/team\/PEPITES\">https:\/\/www.iplesp.upmc.fr\/fr\/team\/PEPITES<\/a><\/p>\n<p><strong>Manager \/ Team Leader<\/strong><\/p>\n<p>Florence TUBACH<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"entry-content\">\n<hr \/>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"template":"","class_list":["post-3282","structure-recherche","type-structure-recherche","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IPLESP - Pierre Louis Institute of Epidemiology and Public Health - IUC - Institut Universitaire de Canc\u00e9rologie<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/iuc-aphp-sorbonneuniversite.com\/en\/structure-recherche\/iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IPLESP - Pierre Louis Institute of Epidemiology and Public Health - IUC - Institut Universitaire de Canc\u00e9rologie\" \/>\n<meta property=\"og:description\" content=\"Summary of the activity The Pierre Louis Institute [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/iuc-aphp-sorbonneuniversite.com\/en\/structure-recherche\/iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique\/\" \/>\n<meta property=\"og:site_name\" content=\"IUC - Institut Universitaire de Canc\u00e9rologie\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-03T14:00:52+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/en\\\/structure-recherche\\\/iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique\\\/\",\"url\":\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/en\\\/structure-recherche\\\/iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique\\\/\",\"name\":\"IPLESP - Pierre Louis Institute of Epidemiology and Public Health - IUC - Institut Universitaire de Canc\u00e9rologie\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/#website\"},\"datePublished\":\"2023-02-16T17:49:32+00:00\",\"dateModified\":\"2023-03-03T14:00:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/en\\\/structure-recherche\\\/iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/en\\\/structure-recherche\\\/iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/en\\\/structure-recherche\\\/iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IPLESP &#8211; Pierre Louis Institute of Epidemiology and Public Health\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/#website\",\"url\":\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/\",\"name\":\"IUC - Institut Universitaire de Canc\u00e9rologie\",\"description\":\"Facult\u00e9 de M\u00e9decine Pierre et Marie Curie\",\"publisher\":{\"@id\":\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/#organization\",\"name\":\"IUC - Institut Universitaire de Canc\u00e9rologie\",\"url\":\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-iuc-e1670571869673.png\",\"contentUrl\":\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-iuc-e1670571869673.png\",\"width\":500,\"height\":103,\"caption\":\"IUC - Institut Universitaire de Canc\u00e9rologie\"},\"image\":{\"@id\":\"https:\\\/\\\/iuc-aphp-sorbonneuniversite.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IPLESP - Pierre Louis Institute of Epidemiology and Public Health - IUC - Institut Universitaire de Canc\u00e9rologie","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/iuc-aphp-sorbonneuniversite.com\/en\/structure-recherche\/iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique\/","og_locale":"en_US","og_type":"article","og_title":"IPLESP - Pierre Louis Institute of Epidemiology and Public Health - IUC - Institut Universitaire de Canc\u00e9rologie","og_description":"Summary of the activity The Pierre Louis Institute [&hellip;]","og_url":"https:\/\/iuc-aphp-sorbonneuniversite.com\/en\/structure-recherche\/iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique\/","og_site_name":"IUC - Institut Universitaire de Canc\u00e9rologie","article_modified_time":"2023-03-03T14:00:52+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/iuc-aphp-sorbonneuniversite.com\/en\/structure-recherche\/iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique\/","url":"https:\/\/iuc-aphp-sorbonneuniversite.com\/en\/structure-recherche\/iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique\/","name":"IPLESP - Pierre Louis Institute of Epidemiology and Public Health - IUC - Institut Universitaire de Canc\u00e9rologie","isPartOf":{"@id":"https:\/\/iuc-aphp-sorbonneuniversite.com\/#website"},"datePublished":"2023-02-16T17:49:32+00:00","dateModified":"2023-03-03T14:00:52+00:00","breadcrumb":{"@id":"https:\/\/iuc-aphp-sorbonneuniversite.com\/en\/structure-recherche\/iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/iuc-aphp-sorbonneuniversite.com\/en\/structure-recherche\/iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/iuc-aphp-sorbonneuniversite.com\/en\/structure-recherche\/iplesp-institute-pierre-louis-depidemiologie-et-de-sante-publique\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/iuc-aphp-sorbonneuniversite.com\/en\/"},{"@type":"ListItem","position":2,"name":"IPLESP &#8211; Pierre Louis Institute of Epidemiology and Public Health"}]},{"@type":"WebSite","@id":"https:\/\/iuc-aphp-sorbonneuniversite.com\/#website","url":"https:\/\/iuc-aphp-sorbonneuniversite.com\/","name":"IUC - Institut Universitaire de Canc\u00e9rologie","description":"Facult\u00e9 de M\u00e9decine Pierre et Marie Curie","publisher":{"@id":"https:\/\/iuc-aphp-sorbonneuniversite.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/iuc-aphp-sorbonneuniversite.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/iuc-aphp-sorbonneuniversite.com\/#organization","name":"IUC - Institut Universitaire de Canc\u00e9rologie","url":"https:\/\/iuc-aphp-sorbonneuniversite.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/iuc-aphp-sorbonneuniversite.com\/#\/schema\/logo\/image\/","url":"https:\/\/iuc-aphp-sorbonneuniversite.com\/wp-content\/uploads\/2022\/10\/logo-iuc-e1670571869673.png","contentUrl":"https:\/\/iuc-aphp-sorbonneuniversite.com\/wp-content\/uploads\/2022\/10\/logo-iuc-e1670571869673.png","width":500,"height":103,"caption":"IUC - Institut Universitaire de Canc\u00e9rologie"},"image":{"@id":"https:\/\/iuc-aphp-sorbonneuniversite.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/iuc-aphp-sorbonneuniversite.com\/en\/wp-json\/wp\/v2\/structure-recherche\/3282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iuc-aphp-sorbonneuniversite.com\/en\/wp-json\/wp\/v2\/structure-recherche"}],"about":[{"href":"https:\/\/iuc-aphp-sorbonneuniversite.com\/en\/wp-json\/wp\/v2\/types\/structure-recherche"}],"wp:attachment":[{"href":"https:\/\/iuc-aphp-sorbonneuniversite.com\/en\/wp-json\/wp\/v2\/media?parent=3282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}